Andrade M de O, Gutierres IG, Sousa RB, Testa L, Ferrari A, Souza ZS de, et al. Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/ GBECAM-0123 study. MAST [Internet]. 2026 Feb. 24 [cited 2026 Apr. 30];35(suppl.1). Available from: https://mastology.org/journal/article/view/1197